Cargando…

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis

The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system forme...

Descripción completa

Detalles Bibliográficos
Autores principales: García-García, Patricia, Reyes, Ricardo, Segredo-Morales, Elisabet, Pérez-Herrero, Edgar, Delgado, Araceli, Évora, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956377/
https://www.ncbi.nlm.nih.gov/pubmed/31817033
http://dx.doi.org/10.3390/pharmaceutics11120648
_version_ 1783487142296551424
author García-García, Patricia
Reyes, Ricardo
Segredo-Morales, Elisabet
Pérez-Herrero, Edgar
Delgado, Araceli
Évora, Carmen
author_facet García-García, Patricia
Reyes, Ricardo
Segredo-Morales, Elisabet
Pérez-Herrero, Edgar
Delgado, Araceli
Évora, Carmen
author_sort García-García, Patricia
collection PubMed
description The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system formed by a hydrogel core composed of chitosan (CHT) collagen, 2-hidroxipropil γ-ciclodextrin (HP-γ-CD), nanoparticles of hydroxyapatite (nano-HAP), and an electrospun mesh shell prepared with two external electrospinning films for the regeneration of a critical bone defect in osteoporotic rats. Microspheres were made with poly-lactide-co-glycolide (PLGA) to encapsulate BMP-2, whereas the different formulations of 17β-estradiol were prepared with poly-lactic acid (PLA) and PLGA. The in vitro and in vivo BMP-2 delivered from the system fitted a biphasic profile. Although the in vivo burst effect was higher than in vitro the second phases (lasted up to 6 weeks) were parallel, the release rate ranged between 55 and 70 ng/day. The in vitro release kinetics of the 17β-estradiol dissolved in the polymeric matrix of the microspheres depended on the partition coefficient. The 17β-estradiol was slowly released from the core system using an aqueous release medium (D(eff) = 5.58·10(−16) ± 9.81·10(−17)m(2)s(−1)) and very fast in MeOH-water (50:50). The hydrogel core system was injectable, and approximately 83% of the loaded dose is uniformly discharged through a 20G needle. The system placed in the defect was easily adapted to the defect shape and after 12 weeks approximately 50% of the defect was refilled by new tissue. None differences were observed between the osteoporotic and non-osteoporotic groups. Despite the role of 17β-estradiol on the bone remodeling process, the obtained results in this study suggest that the observed regeneration was only due to the controlled rate released of BMP-2 from the PLGA microspheres.
format Online
Article
Text
id pubmed-6956377
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69563772020-01-23 PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis García-García, Patricia Reyes, Ricardo Segredo-Morales, Elisabet Pérez-Herrero, Edgar Delgado, Araceli Évora, Carmen Pharmaceutics Article The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system formed by a hydrogel core composed of chitosan (CHT) collagen, 2-hidroxipropil γ-ciclodextrin (HP-γ-CD), nanoparticles of hydroxyapatite (nano-HAP), and an electrospun mesh shell prepared with two external electrospinning films for the regeneration of a critical bone defect in osteoporotic rats. Microspheres were made with poly-lactide-co-glycolide (PLGA) to encapsulate BMP-2, whereas the different formulations of 17β-estradiol were prepared with poly-lactic acid (PLA) and PLGA. The in vitro and in vivo BMP-2 delivered from the system fitted a biphasic profile. Although the in vivo burst effect was higher than in vitro the second phases (lasted up to 6 weeks) were parallel, the release rate ranged between 55 and 70 ng/day. The in vitro release kinetics of the 17β-estradiol dissolved in the polymeric matrix of the microspheres depended on the partition coefficient. The 17β-estradiol was slowly released from the core system using an aqueous release medium (D(eff) = 5.58·10(−16) ± 9.81·10(−17)m(2)s(−1)) and very fast in MeOH-water (50:50). The hydrogel core system was injectable, and approximately 83% of the loaded dose is uniformly discharged through a 20G needle. The system placed in the defect was easily adapted to the defect shape and after 12 weeks approximately 50% of the defect was refilled by new tissue. None differences were observed between the osteoporotic and non-osteoporotic groups. Despite the role of 17β-estradiol on the bone remodeling process, the obtained results in this study suggest that the observed regeneration was only due to the controlled rate released of BMP-2 from the PLGA microspheres. MDPI 2019-12-03 /pmc/articles/PMC6956377/ /pubmed/31817033 http://dx.doi.org/10.3390/pharmaceutics11120648 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
García-García, Patricia
Reyes, Ricardo
Segredo-Morales, Elisabet
Pérez-Herrero, Edgar
Delgado, Araceli
Évora, Carmen
PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title_full PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title_fullStr PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title_full_unstemmed PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title_short PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
title_sort plga-bmp-2 and pla-17β-estradiol microspheres reinforcing a composite hydrogel for bone regeneration in osteoporosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956377/
https://www.ncbi.nlm.nih.gov/pubmed/31817033
http://dx.doi.org/10.3390/pharmaceutics11120648
work_keys_str_mv AT garciagarciapatricia plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis
AT reyesricardo plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis
AT segredomoraleselisabet plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis
AT perezherreroedgar plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis
AT delgadoaraceli plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis
AT evoracarmen plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis